Incyte
INCY
#1180
Rank
โ‚น1.775 T
Marketcap
โ‚น8,921
Share price
1.73%
Change (1 day)
67.82%
Change (1 year)

Earnings for Incyte (INCY)

Earnings in 2025 (TTM): โ‚น145.69 Billion

According to Incyte's latest financial reports the company's current earnings are โ‚น5.14 Billion. , an increase over its 2024 earnings that were of โ‚น29.44 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Incyte from 1994 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น154.78 B425.68%
2024 โ‚น29.44 B-62.04%
2023 โ‚น77.57 B57.66%
2022 โ‚น49.20 B-7.24%
2021 โ‚น53.04 B-345.65%
2020 -โ‚น21.6 Billion-147.7%
2019 โ‚น45.26 B322.02%
2018 โ‚น10.72 B-136.94%
2017 -โ‚น29.05 Billion-390.76%
2016 โ‚น9.98 B1322%
2015 โ‚น0.70 B-115.56%
2014 -โ‚น4.52 Billion-41.4%
2013 -โ‚น7.71 Billion87.67%
2012 -โ‚น4.11 Billion-74.9%
2011 -โ‚น16.36 Billion843.59%
2010 -โ‚น1.74 Billion-88.68%
2009 -โ‚น15.32 Billion1.37%
2008 -โ‚น15.11 Billion86.16%
2007 -โ‚น8.12 Billion17.64%
2006 -โ‚น6.9 Billion-28.62%
2005 -โ‚น9.67 Billion-36.1%
2004 -โ‚น15.13 Billion-2.03%
2003 -โ‚น15.44 Billion22.26%
2002 -โ‚น12.63 Billion-27.39%
2001 -โ‚น17.39 Billion198.72%
2000 -โ‚น5.83 Billion132.2%
1999 -โ‚น2.51 Billion-556.86%
1998 โ‚น0.54 B-37.23%
1997 โ‚น0.87 B-259.32%
1996 -โ‚น0.55 Billion-45.87%
1995 -โ‚น1.02 Billion-9.17%
1994 -โ‚น1.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚น1.520 T 882.43%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น947.78 B 512.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.392 T 1,445.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น834.70 B 439.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น15.22 B-90.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-โ‚น4.28 Billion-102.76%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-โ‚น6.44 Billion-104.16%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-โ‚น2.71 Billion-101.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚น5.17 Billion-103.34%๐Ÿ‡บ๐Ÿ‡ธ USA